Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults (Q34004009)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults |
scientific article |
Statements
1 reference
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults (English)
1 reference
Michel Moutschen
1 reference
Philippe Léonard
1 reference
Etienne M Sokal
1 reference
Françoise Smets
1 reference
Michèle Haumont
1 reference
Pasqualina Mazzu
1 reference
Alex Bollen
1 reference
Francoise Denamur
1 reference
Pascal Peeters
1 reference
Gary Dubin
1 reference
Martine Denis
1 reference
18 April 2007
1 reference
1 reference
25
1 reference
24
1 reference
4697-4705
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference